Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Metyrapone
Drug ID BADD_D01450
Description An inhibitor of the enzyme steroid 11-beta-monooxygenase. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of cushing syndrome.
Indications and Usage Used as a diagnostic drug for testing hypothalamic-pituitary ACTH function. Occasionally used in Cushing's syndrome.
Marketing Status Prescription; Discontinued
ATC Code V04CD01
DrugBank ID DB01011
KEGG ID D00410
MeSH ID D008797
PubChem ID 4174
TTD Drug ID D0Q9JT
NDC Product Code 70219-0001; 55361-0011; 76336-455
Synonyms Metyrapone | Methbipyranone | Methopyrapone | SU 4885 | Metopirone | Métopirone | Metopiron
Chemical Information
Molecular Formula C14H14N2O
CAS Registry Number 54-36-4
SMILES CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rhabdomyolysis15.05.05.0020.000388%
Sedation17.02.04.005--Not Available
Skin disorder23.03.03.007--Not Available
Vomiting07.01.07.003--
White blood cell count decreased13.01.06.012--
Deep vein thrombosis24.01.02.0030.000776%Not Available
Transaminases increased13.03.01.0150.000388%Not Available
Angiopathy24.03.02.007--Not Available
Bone marrow failure01.03.03.005--
Low birth weight baby18.04.02.0030.000152%Not Available
Pneumocystis jirovecii pneumonia22.07.08.009; 11.03.07.0050.000607%Not Available
Cortisol free urine increased13.10.09.0110.000388%Not Available
The 2th Page    First    Pre   2    Total 2 Pages